Rei Noguchi

932 total citations
74 papers, 446 citations indexed

About

Rei Noguchi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Rei Noguchi has authored 74 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Rei Noguchi's work include Sarcoma Diagnosis and Treatment (55 papers), Oral and Maxillofacial Pathology (12 papers) and Bone Tumor Diagnosis and Treatments (12 papers). Rei Noguchi is often cited by papers focused on Sarcoma Diagnosis and Treatment (55 papers), Oral and Maxillofacial Pathology (12 papers) and Bone Tumor Diagnosis and Treatments (12 papers). Rei Noguchi collaborates with scholars based in Japan, United Kingdom and United States. Rei Noguchi's co-authors include Tadashi Kondo, Yuki Yoshimatsu, Akira Kawai, Akihiko Yoshida, Ryuto Tsuchiya, Takuya Ono, Kiyoshi Yamaguchi, Yoichi Furukawa, Tsuneo Ikenoue and Yumi Terakado and has published in prestigious journals such as Scientific Reports, Autophagy and Cells.

In The Last Decade

Rei Noguchi

64 papers receiving 443 citations

Peers

Rei Noguchi

PRM

ONCOL

SURGE

Kenji Koda Japan

Josh Haimes United States

Seog-Yun Park South Korea

Raghu Chandramohan United States

S. Scheil-Bertram Germany

Jin Haeng Chung South Korea

Tien Anh N. Tran United States

Esther O’Regan Ireland

Patricia C. Ewing‐Graham Netherlands

David Hernández Gonzalo United States

Kenji Koda Japan

Rei Noguchi

158 ×0.7

PRM

147 ×0.9

ONCOL

252 ×1.9

SURGE

129 ×1.0

57 ×0.7

Citations per year, relative to Rei Noguchi Rei Noguchi (= 1×) peers Kenji Koda

Countries citing papers authored by Rei Noguchi

Since Specialization

Citations

This map shows the geographic impact of Rei Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rei Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rei Noguchi more than expected).

Fields of papers citing papers by Rei Noguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rei Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rei Noguchi. The network helps show where Rei Noguchi may publish in the future.

Co-authorship network of co-authors of Rei Noguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Rei Noguchi. A scholar is included among the top collaborators of Rei Noguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rei Noguchi. Rei Noguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noguchi, Rei, Takuya Ono, Kazuki Sasaki, et al.. (2025). Pharmacokinomic Profiling Using Patient-Derived Cell Lines Predicts Sensitivity to Imatinib in Dermatofibrosarcoma Protuberans. Cells. 14(12). 884–884.

Noguchi, Rei, et al.. (2025). Establishment and characterization of NCC-OS2-C1: a novel patient-derived cell line of osteosarcoma. Human Cell. 38(3). 81–81.

Noguchi, Rei, Takuya Ono, Taro E. Akiyama, et al.. (2024). Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone: NCC-GCTB8-C1 and NCC-GCTB9-C1. Human Cell. 37(3). 874–885. 4 indexed citations

Noguchi, Rei, Takuya Ono, Taro E. Akiyama, et al.. (2024). Establishment and characterization of two novel patient-derived cell lines from myxofibrosarcoma: NCC-MFS7-C1 and NCC-MFS8-C1. Human Cell. 37(6). 1742–1750.

Noguchi, Rei, Takuya Ono, Kazuyoshi Yanagihara, et al.. (2024). Establishment and characterization of a novel patient-derived cell line from conventional central grade 3 chondrosarcoma, NCC-CS1-C1. Human Cell. 38(1). 28–28. 1 indexed citations

Noguchi, Rei, Takuya Ono, Taro E. Akiyama, et al.. (2024). Establishment and characterization of NCC-GCTB10-C1: a novel cell line derived from a patient with recurrent giant cell tumor of bone. Human Cell. 38(1). 29–29. 1 indexed citations

Ono, Takuya, Rei Noguchi, Taro E. Akiyama, et al.. (2024). Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line. Human Cell. 37(3). 854–864. 1 indexed citations

Noguchi, Rei, Kazuyoshi Yanagihara, Takuya Ono, et al.. (2024). Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma. Human Cell. 37(3). 865–873.

Yoshimatsu, Yuki, Rei Noguchi, Ryuto Tsuchiya, et al.. (2022). Establishment and characterization of NCC-DDLPS5-C1: a novel patient-derived cell line of dedifferentiated liposarcoma. Human Cell. 35(3). 936–943. 1 indexed citations

10.

Tsuchiya, Ryuto, Yuki Yoshimatsu, Rei Noguchi, et al.. (2021). Establishment and Characterization of NCC-DDLPS4-C1: A Novel Patient-Derived Cell Line of Dedifferentiated Liposarcoma. Journal of Personalized Medicine. 11(11). 1075–1075. 3 indexed citations

11.

Yoshimatsu, Yuki, Rei Noguchi, Ryuto Tsuchiya, et al.. (2021). Establishment and characterization of novel patient-derived cell lines from giant cell tumor of bone. Human Cell. 34(6). 1899–1910. 12 indexed citations

12.

Tsuchiya, Ryuto, Yuki Yoshimatsu, Rei Noguchi, et al.. (2021). Establishment and characterization of NCC-SS4-C1: a novel patient-derived cell line of synovial sarcoma. Human Cell. 34(3). 998–1007. 6 indexed citations

13.

Yoshimatsu, Yuki, Rei Noguchi, Ryuto Tsuchiya, et al.. (2021). Establishment and characterization of NCC-LGFMS1-C1: a novel patient-derived cell line of low-grade fibromyxoid sarcoma. Human Cell. 34(6). 1919–1928. 1 indexed citations

14.

Yoshimatsu, Yuki, Rei Noguchi, Ryuto Tsuchiya, et al.. (2020). Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1. Human Cell. 33(4). 1311–1320. 6 indexed citations

15.

Nakano, Yoshiko, Makoto Miyazaki, Zhiwei Qiao, et al.. (2020). Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor. Human Cell. 34(1). 271–278. 3 indexed citations

16.

Yoshimatsu, Yuki, Rei Noguchi, Ryuto Tsuchiya, et al.. (2020). Establishment and characterization of NCC-SS3-C1: a novel patient-derived cell line of synovial sarcoma. Human Cell. 33(3). 877–885. 7 indexed citations

17.

Yoshimatsu, Yuki, Rei Noguchi, Ryuto Tsuchiya, et al.. (2020). Establishment and characterization of NCC-ssRMS1-C1: a novel patient-derived spindle-cell/sclerosing rhabdomyosarcoma cell line. Human Cell. 33(3). 886–893. 3 indexed citations

18.

Yamaguchi, Kiyoshi, Eigo Shimizu, Rui Yamaguchi, et al.. (2019). Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient. Journal of Human Genetics. 64(8). 729–740. 7 indexed citations

19.

Oyama, Rieko, Zhiwei Qiao, Rei Noguchi, et al.. (2018). Establishment of a novel patient-derived Ewing’s sarcoma cell line, NCC-ES1-C1. In Vitro Cellular & Developmental Biology - Animal. 54(10). 770–778. 7 indexed citations

20.

Noguchi, Rei, Kiyoshi Yamaguchi, Tsuneo Ikenoue, et al.. (2017). Genetic alterations in Japanese extrahepatic biliary tract cancer. Oncology Letters. 14(1). 877–884. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact